Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma

被引：3
|
作者：
Jiang, Jing-Hang [2 ]
Zhong, Jian-Hong [1 ]
机构：
[1] Affiliated Tumor Hosp Guangxi Med Univ, Hepatobiliary Surg Dept, Nanning 530021, PR, Peoples R China
[2] Second Peoples Hosp, Dept Gen Surg, Jingmen 448000, PR, Peoples R China
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2016年 / 40卷 / 03期
关键词：
D O I：
10.1016/j.clinre.2015.09.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E29 / E30
页数：2
相关论文
共 50 条
  • [31] High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Lin, Ching-Chung
    Bair, Ming-Jong
    Liu, Chia-Yuan
    Lin, Ze-Yu
    Chen, Chih-Jen
    Chen, Ming-Jen
    Chu, Cheng-Hsin
    Wang, Horng-Yuan
    Shih, Shou-Chuan
    Wang, Tsang-En
    MEDICINE, 2019, 98 (01) : E13818
  • [32] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, (03) : 158 - 164
  • [33] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (39) : 6515 - 6522
  • [34] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Il Han Song
    So Mi Kim
    Young Kwang Choo
    World Journal of Gastroenterology, 2013, (47) : 8867 - 8872
  • [35] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Song, Il Han
    Kim, So Mi
    Choo, Young Kwang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (47) : 8867 - 8872
  • [36] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, 10 (03) : 158 - 164
  • [37] Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
    Xu, Li
    Gao, Hengjun
    Huang, Junting
    Wang, Haoyuan
    Zhou, Zhongguo
    Zhang, Yaojun
    Li, Shaohua
    Chen, Minshan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (06) : 1032 - 1039
  • [38] RISK OF RECURRENCE IN HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA PATIENTS FAILED IN NUCLEOS(T) IDE ANALOGUES (NUCS) SECONDARY PREVENTION - A NATIONWIDE COHORT STUDY
    Lee, I-C.
    Wang, T-H.
    Hu, Y-W.
    Lin, H-C.
    Chao, Y.
    Huang, Y-H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S327 - S327
  • [39] Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Hiyama, Yuichi
    Fujino, Hatsue
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 981 - 992
  • [40] Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
    Liu, Shi
    Deng, Rui
    Zhou, Bin
    Liang, Xieer
    Liu, Zhihong
    Peng, Jie
    Chen, Jinjun
    Zhou, Yuanping
    Guo, Yabing
    Chen, Yongpeng
    Li, Wanying
    Shen, Sheng
    Lu, Xingyu
    Zhao, Siru
    Liao, Xingmei
    Liang, Hongyan
    Lan, Yu
    Hou, Jinlin
    Fan, Rong
    Sun, Jian
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05): : 881 - 890
12345